BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

645 related articles for article (PubMed ID: 22088988)

  • 21. Long noncoding RNA VPS9D1-AS1 overexpression predicts a poor prognosis in non-small cell lung cancer.
    Tan J; Yang L
    Biomed Pharmacother; 2018 Oct; 106():1600-1606. PubMed ID: 30119235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
    Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
    Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The long non-coding RNA, GAS5, enhances gefitinib-induced cell death in innate EGFR tyrosine kinase inhibitor-resistant lung adenocarcinoma cells with wide-type EGFR via downregulation of the IGF-1R expression.
    Dong S; Qu X; Li W; Zhong X; Li P; Yang S; Chen X; Shao M; Zhang L
    J Hematol Oncol; 2015 Apr; 8():43. PubMed ID: 25925741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts.
    Zhang W; Chen Y; Wei H; Zheng C; Sun R; Zhang J; Tian Z
    Clin Cancer Res; 2008 Oct; 14(20):6432-9. PubMed ID: 18927282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The 3' UTR IGF2R-A2/B2 variant is associated with increased tumor growth and advanced stages in non-small cell lung cancer.
    Kotsinas A; Evangelou K; Sideridou M; Kotzamanis G; Constantinides C; Zavras AI; Douglass CW; Papavassiliou AG; Gorgoulis VG
    Cancer Lett; 2008 Feb; 259(2):177-85. PubMed ID: 18037232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biological function and mechanism of MALAT-1 in renal cell carcinoma proliferation and apoptosis: role of the MALAT-1-Livin protein interaction.
    Chen S; Ma P; Zhao Y; Li B; Jiang S; Xiong H; Wang Z; Wang H; Jin X; Liu C
    J Physiol Sci; 2017 Sep; 67(5):577-585. PubMed ID: 27655020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long noncoding RNA XIST acts as an oncogene in non-small cell lung cancer by epigenetically repressing KLF2 expression.
    Fang J; Sun CC; Gong C
    Biochem Biophys Res Commun; 2016 Sep; 478(2):811-7. PubMed ID: 27501756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of high expression levels of STK39 in the growth, migration and invasion of non-small cell type lung cancer cells.
    Li Z; Zhu W; Xiong L; Yu X; Chen X; Lin Q
    Oncotarget; 2016 Sep; 7(38):61366-61377. PubMed ID: 27542260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Large noncoding RNA HOTAIR enhances aggressive biological behavior and is associated with short disease-free survival in human non-small cell lung cancer.
    Nakagawa T; Endo H; Yokoyama M; Abe J; Tamai K; Tanaka N; Sato I; Takahashi S; Kondo T; Satoh K
    Biochem Biophys Res Commun; 2013 Jun; 436(2):319-24. PubMed ID: 23743197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pseudogene-derived long noncoding RNA SFTA1P is down-regulated and suppresses cell migration and invasion in lung adenocarcinoma.
    Zhang H; Xiong Y; Xia R; Wei C; Shi X; Nie F
    Tumour Biol; 2017 Feb; 39(2):1010428317691418. PubMed ID: 28231733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MALAT-1 Expression Correlates with Prognosis in Non-Small-Cell Lung Carcinoma: A Systematic Review and Meta-analysis.
    Ran R; Jin JW; Zhang WP
    Dis Markers; 2021; 2021():5424623. PubMed ID: 34858541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated expression level of long noncoding RNA MALAT-1 facilitates cell growth, migration and invasion in pancreatic cancer.
    Jiao F; Hu H; Yuan C; Wang L; Jiang W; Jin Z; Guo Z; Wang L
    Oncol Rep; 2014 Dec; 32(6):2485-92. PubMed ID: 25269958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppression of non-small cell lung cancer proliferation and tumorigenicity by DENND2D.
    Ling B; Zheng H; Fu G; Yuan J; Shi T; Chen S; Liu Y; Liu Y; Cao Y; Zheng S; Guo S; Han N; Gao Y; Cheng S; Zhang K
    Lung Cancer; 2013 Feb; 79(2):104-10. PubMed ID: 23182661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Roles of noncoding RNAs in metastasis of nonsmall cell lung cancer: A mini review.
    Wu T; Yin X; Zhou Y; Wang Z; Shen S; Qiu Y; Sun R; Zhao Z
    J Cancer Res Ther; 2015 Aug; 11 Suppl 1():C7-10. PubMed ID: 26323929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The cystic fibrosis transmembrane conductance regulator as a biomarker in non-small cell lung cancer.
    Li J; Zhang JT; Jiang X; Shi X; Shen J; Feng F; Chen J; Liu G; He P; Jiang J; Tsang LL; Wang Y; Rosell R; Jiang L; He J; Chan HC
    Int J Oncol; 2015 May; 46(5):2107-15. PubMed ID: 25760446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DDX5 promotes proliferation and tumorigenesis of non-small-cell lung cancer cells by activating β-catenin signaling pathway.
    Wang Z; Luo Z; Zhou L; Li X; Jiang T; Fu E
    Cancer Sci; 2015 Oct; 106(10):1303-12. PubMed ID: 26212035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrin alpha 11 regulates IGF2 expression in fibroblasts to enhance tumorigenicity of human non-small-cell lung cancer cells.
    Zhu CQ; Popova SN; Brown ER; Barsyte-Lovejoy D; Navab R; Shih W; Li M; Lu M; Jurisica I; Penn LZ; Gullberg D; Tsao MS
    Proc Natl Acad Sci U S A; 2007 Jul; 104(28):11754-9. PubMed ID: 17600088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MALAT-1 enhances cell motility of lung adenocarcinoma cells by influencing the expression of motility-related genes.
    Tano K; Mizuno R; Okada T; Rakwal R; Shibato J; Masuo Y; Ijiri K; Akimitsu N
    FEBS Lett; 2010 Nov; 584(22):4575-80. PubMed ID: 20937273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of adenylate cyclase-associated protein 1 is associated with metastasis of lung cancer.
    Tan M; Song X; Zhang G; Peng A; Li X; Li M; Liu Y; Wang C
    Oncol Rep; 2013 Oct; 30(4):1639-44. PubMed ID: 23842884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NDRG1/Cap43/Drg-1 may predict tumor angiogenesis and poor outcome in patients with lung cancer.
    Azuma K; Kawahara A; Hattori S; Taira T; Tsurutani J; Watari K; Shibata T; Murakami Y; Takamori S; Ono M; Izumi H; Kage M; Yanagawa T; Nakagawa K; Hoshino T; Kuwano M
    J Thorac Oncol; 2012 May; 7(5):779-89. PubMed ID: 22481237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.